Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.1%

2 terminated/withdrawn out of 65 trials

Success Rate

96.1%

+9.6% vs industry average

Late-Stage Pipeline

5%

3 trials in Phase 3/4

Results Transparency

0%

0 of 49 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

N/A
39(83.0%)
Phase 2
5(10.6%)
Phase 3
3(6.4%)
47Total
N/A(39)
Phase 2(5)
Phase 3(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (65)

Showing 20 of 65 trials
NCT07326800Not ApplicableRecruiting

Efficacy of the MAEva Program (Meditation, Acceptance, and Commitment to Values) Among Patients Treated For Breast Cancer.

Role: lead

NCT02865837Not ApplicableCompleted

Effect of Bladder Distension on Dosimetry in Brachytherapy of Cervical Cancer

Role: lead

NCT06435546Not ApplicableCompleted

Adherence to Oral Therapies in Advanced Breast and Prostate Cancers

Role: lead

NCT02676349Phase 2Completed

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

Role: lead

NCT06552091Not ApplicableRecruiting

Guided Digital Self-Hypnosis Solution for Managing Hot Flashes in Patients Undergoing Adjuvant Hormone Therapy

Role: lead

NCT04866680Not ApplicableActive Not Recruiting

Personalized Circulating DNA Follow-up in Melanoma (PERCIMEL)

Role: lead

NCT03832920Completed

Analgesia Nociception Index (ANI) After Unilateral Radical Mastectomy as an Evaluation of Paravertebral Block Failure

Role: lead

NCT06903104Not ApplicableCompleted

Acceptability and Feasibility of a Stress Prevention Program Based on Meditation and Acceptance and Commitment Therapy for Staff at a Cancer Center

Role: lead

NCT06479070Not ApplicableRecruiting

Prognostic Value of Measuring CtDNA in a Cohort of Patients With Stage III and IV Upper Aero-digestive Tract (UADT) Cancer , Treated With Curative RADiOtherapy With or Without Concomitant Treatment.

Role: lead

NCT07165756Recruiting

"Mon Parcours de Vie" Localized Breast Cancer: Announcement, Support, Information on the Disease and Treatments. Pilot Study to Assess the Value of Written Information Documents.

Role: lead

NCT05538000Not ApplicableActive Not Recruiting

Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog)

Role: lead

NCT05935995Not ApplicableActive Not Recruiting

Intraoperative Assessment of Surgical Margins Using Confocal Microscopy in Comparison With Reference Extemporaneous Examination

Role: lead

NCT05936034Not ApplicableRecruiting

Comparative Study of the Quality of Life of Patients Suffering From OTOTOXICITY Due to Chemotherapy Based on Platinum Salts Fitted With a Hearing Aid Compared to Those Not Fitted.

Role: lead

NCT03755895Phase 2Completed

Contribution of Hypnosis to Anxiety and Pain in Brachytherapy Patients

Role: lead

NCT07089485Not ApplicableNot Yet Recruiting

Impact of Anesthesia Alarm Volume on Mental Workload in Surgical Trainees

Role: lead

NCT06884332Not ApplicableRecruiting

Spinal Palliation in Irradiation for Neoplastic Analgesia and Life Quality

Role: lead

NCT03919149Completed

Psycho-social Determinant for Sport Practised During Cancer

Role: lead

NCT04511988Not ApplicableActive Not Recruiting

Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal

Role: lead

NCT04766502Not ApplicableCompleted

Bonds Between Circulating Tumoral ADN (ctDNA) and the Development of Peritoneal Carcinomatosis for Patients Under PIPAC

Role: lead

NCT04671485Not ApplicableCompleted

Effectiveness of autoHYpnosis in the Prevention of Anxiety During Radiotherapy of Head and Neck Tumors (HYMACO)

Role: lead